8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Jul 13, 2005)

Filed July 13, 2005For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on July 13, 2005, to report its financial results for the second quarter of 2005. The filing primarily references a press release (Exhibit 99.1) that contains the detailed earnings information. Investors should note that Abbott utilizes non-GAAP financial measures, such as earnings from continuing operations excluding one-time charges and diluted earnings per common share excluding one-time charges, to provide a clearer view of ongoing business performance. The company emphasizes that these non-GAAP measures are intended to supplement, not replace, GAAP-based financial reporting.

Key Highlights

  • 1Abbott Laboratories announced its second quarter 2005 financial results.
  • 2The 8-K filing incorporates a press release (Exhibit 99.1) containing the detailed results.
  • 3The company used non-GAAP financial measures, including adjusted earnings and diluted EPS, in its reporting.
  • 4Abbott's management believes these non-GAAP measures offer valuable insights into ongoing business performance.
  • 5These non-GAAP measures are presented to allow investors to better evaluate performance, excluding unusual or unpredictable factors.
  • 6Abbott cautions investors to consider non-GAAP measures alongside, and not as a substitute for, GAAP financial measures.

Frequently Asked Questions

This 8-K filing is primarily to report Abbott Laboratories' financial results for the second quarter of 2005. It incorporates by reference a press release that contains the detailed earnings announcement.

Abbott used both GAAP (Generally Accepted Accounting Principles) financial measures and non-GAAP financial measures. Notably, they presented earnings from continuing operations and diluted earnings per common share, adjusted to exclude one-time charges.

Abbott's management uses non-GAAP measures to provide investors with a better understanding of the company's ongoing business performance by excluding unusual or unpredictable items. Management also uses these measures internally for performance monitoring.

Abbott advises investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, the financial measures prepared in accordance with GAAP. This means GAAP figures remain the primary financial reporting standard.